Five-year outcomes of the IDEA trial of endocrine therapy without radiotherapy after breast-conserving surgery for postmenopausal patients age 50-69 with genomically-selected favorable Stage I breast cancer

Development and Validation of a Genomic Prole for the Omission of Local Adjuvant Radiation in Breast Cancer